<DOC>
	<DOCNO>NCT01531933</DOCNO>
	<brief_summary>This 2-arm , prospective , double blind , randomize , control clinical study 12 week therapy investigate clinical efficacy safety DLBS3233 . It hypothesize DLBS3233 delay progress beta-cell dysfunction measure improvement prandial ( particularly first phase ) insulin secretion well insulin resistance prediabetic subject may prevent conversion prediabetes type 2 diabetes mellitus .</brief_summary>
	<brief_title>Efficacy Safety DLBS3233 Prediabetic Patients</brief_title>
	<detailed_description>There two group treatment study receive DLBS3233 placebo DLBS3233 12 week therapy . Subjects provide education lifestyle modification give assigned nutritionist . All subject advise follow lifestyle modification throughout study period . All subject direct supervision medical doctor study period . All clinical laboratory examination evaluate investigational drug 's efficacy , perform baseline , Week 8th Week 12th ( end ) study treatment . Blood glucose level ( FPG 2h-PG ) perform baseline interval 4 week 12 week study treatment . Safety examination perform baseline end study . Occurrence adverse event observe study .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<criteria>Male female subject age 1860 year Prediabetic patient ( 2hPPPG level 140199 mg/dL ) Serum ALT â‰¤ 2.5 time upper limit normal Serum creatinine &lt; 1.5 time upper limit normal Able take oral medication Female childbearing potential History diabetes mellitus History symptomatic coronary arterial disease , stroke , cardiovascular event Current treatment systemic corticosteroid herbal ( alternative ) medicine Any disease state uncontrolled illness , judge investigator , could interfere trial participation trial evaluation Participation clinical study within 30 day prior screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Prediabetic</keyword>
	<keyword>Primary prevention</keyword>
	<keyword>Type 2 diabetes mellitus</keyword>
</DOC>